《盈警响号》微创医疗(00853.HK)料年度转蚀1.88-2.03亿美元
微创医疗(00853.HK)发盈警,预计2020年止年度录得亏损介乎1.88-2.03亿美元,相对上一年度利润4,630万美元。主要受新型冠状病毒肺炎疫情影响医疗机构门诊量及手术量锐减,导致集团植入类器械销售收入下降;受四季度中国冠脉支架集中带量采购政策的影响,集团对渠道中已售但未植入支架产品参照2021年执行价格所计提的价格补贴调整;股份奖励计划所确认的成本;及未有上年同期处置上海微创电生理部分股权获取的一次性投资收益。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.